Ayca Gucalp

Years Active: 2017-2020
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Ian Krop, Vandana G Abramson, Marco Colleoni, Tiffany Traina, Frankie Ann Holmes, Laura Garcia-Estevez, Lowell Hart, Ahmad Awada, Claudio Zamagni, Patrick G Morris, Lee Schwartzberg, Stephen Chan, Ayca Gucalp, Laura Biganzoli, Joyce Steinberg, Lorenzo Sica, Maureen Trudeau, Denka Markova, Jamal C Tarazi, Zhou Zhu, Thomas O'Brien, Catherine M Kelly, Eric P Winer, Denise A Yardley
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Alice Y Ho, Christopher A Barker, Brittany B Arnold, Simon N Powell, Zishuo I Hu, Ayca Gucalp, Lizza Lebron-Zapata, Hannah Y Wen, Cindy Kallman, Alessandro D'Agnolo, Zhigang Zhang, Jessica Flynn, Samantha A Dunn, Heather L McArthur
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer. Cancer 126 (4) (2019)
Ayca Gucalp, Tiffany A Traina, Joel R Eisner, Joel S Parker, Sara R Selitsky, Ben H Park, Anthony D Elias, Edwina S Baskin-Bey, Fatima Cardoso
Male breast cancer: a disease distinct from female breast cancer. Breast cancer research and treatment 173 (1) (2018)
Ayca Gucalp, Tiffany A Traina
Androgen receptor-positive, triple-negative breast cancer. Cancer 123 (10) (2017)

Ayca Gucalp.css-eqlu8i{font-size:small;padding-left:4px;}